Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves combination therapy Juvisync

October 7, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.

Post navigation

← Fruit Fresh Up, Inc. Recalls Fresh Cut Cantaloupe and Cut Mixed Fruit Containing Cantaloupe Distributed in New York State Because of Possible Health Risk Whole Milk With An Expiration Date Of 10/22/11 From Farmers All Natural Creamery Voluntarily Recalled Due To Possible Health Concerns →
Proudly powered by WordPress